{"schema_version":"secwatch.filing_event.v1","accession":"0001217234-25-000036","form_type":"8-K","ticker":"CDNA","cik":"0001217234","company_name":"CareDx, Inc.","filed_at":"2025-04-30T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.737008+00:00","generated_at":"2026-05-23T02:02:02.101280+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"CareDx Q1 revenue $84.7M (+18% YoY); GAAP net loss narrows to $10.4M; non-GAAP net income $5.4M","bullets":["Revenue $84.7M (+18% YoY); testing services revenue $61.9M (+15%), volume ~47,100 (+12% YoY).","GAAP net loss $10.4M ($0.19 loss per share) vs $19.9M ($0.38) prior year; non-GAAP net income $5.4M ($0.09 diluted).","Adjusted EBITDA $4.6M vs loss $1.9M; cash $231M, no debt.","Reaffirms FY2025 revenue guidance $365-375M, adjusted EBITDA $29-33M; 2027 targets $500M rev, $100M EBITDA.","Launched AlloSure Heart for pediatric and AlloSure Kidney for SPK; presented AlloHeme data at TANDEM and EBMT."],"urls":{"canonical":"https://secwatch.observer/filing/0001217234-25-000036","json":"https://secwatch.observer/filing/0001217234-25-000036.json","markdown":"https://secwatch.observer/filing/0001217234-25-000036.md","text":"https://secwatch.observer/filing/0001217234-25-000036.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1217234/000121723425000036/0001217234-25-000036-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1217234/000121723425000036/cdna-20250430.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T02:02:02.101280+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}